LyondellBasell Industries NV vs Smith & Nephew plc — how do they compare? LyondellBasell Industries NV trades at $63.73 (market cap $20.67B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: LyondellBasell Industries NV is the larger of the two by market cap, and LyondellBasell Industries NV pays the higher dividend (6.44%). Which is the better fit depends on your goals.
| LYB | SNN | |
|---|---|---|
Market Cap | $20.67B | $12.54B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $38.70 |
52-Week Low | $42.28 | $28.73 |
Enterprise Value | $32.26B | $15.57B |
Dividend Yield | 6.44% | 2.65% |
Trailing returns across standard periods
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →